The Toro Aspiration Catheter, with the Toro Aspiration Tubing and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy or who fail thrombolytic drug therapy are candidates for treatment. The Toro Aspiration Tubing is intended to connect the Toro Aspiration Catheter to the canister of a compatible aspiration pump and to allow the user to control the fluid flow.
Device Story
The Toro 71 Aspiration Catheter is a variable-stiffness, single-lumen catheter designed for thrombus removal from tortuous neurovasculature via aspiration. It features a stainless steel/nitinol wire-reinforced shaft, internal lubricious liner, and distal hydrophilic coating. The Toro Aspiration Tubing connects the catheter to a compatible high-flow/high-vacuum aspiration pump and includes a flow control switch for vacuum regulation. Used in clinical settings by neurointerventionalists, the device is advanced over a guidewire/microcatheter to the occlusion site under fluoroscopic guidance. Aspiration is applied to remove the thrombus, facilitating revascularization. The device benefits patients by restoring blood flow in acute ischemic stroke cases. The system is supplied sterile for single use.
Clinical Evidence
No clinical data. Evidence consists of bench performance testing and a GLP animal study in a porcine model (n=6). Animal study evaluated safety, performance, and usability at 2-3 and 30-32 day timepoints, including thrombectomy of firm/soft clots and simulated aspiration. Results showed no significant health concerns, unremarkable clinical pathology, and histological data comparable to control devices.
Technological Characteristics
Variable-stiffness catheter; stainless steel and nitinol wire reinforcement; hydrophilic coating; single radiopaque tip marker. Dimensions: 0.071" ID, 0.083" OD. Sterilization: Ethylene Oxide (SAL 10^-6). Tubing: braided polymer with flow control switch. Standards: ISO 10555-1:2023, ISO 10993-1, ISO 80369-7:2021, ISO 80369-20:2024, IEC 62366-1:2015/Amd 1:2020.
Indications for Use
Indicated for adults (≥22 years) with acute ischemic stroke secondary to intracranial large vessel occlusive disease (internal carotid, M1/M2 middle cerebral, basilar, and vertebral arteries) within 8 hours of symptom onset. Candidates include patients ineligible for or failing intravenous thrombolytic therapy.
Regulatory Classification
Identification
A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.
{1}
FDA U.S. FOOD & DRUG
ADMINISTRATION
October 21, 2026
Toro Neurovascular, Inc.
Ryan Walker
Co-Founder and Chief Operating Officer
470 Wald
Irvine, California 92618
Re: K262021
Trade/Device Name: Toro 71 Aspiration Catheter; Toro Aspiration Tubing
Regulation Number: 21 CFR 870.1250
Regulation Name: Percutaneous Catheter
Regulatory Class: Class II
Product Code: NRY
Dated: September 18, 2026
Received: September 21, 2026
Dear Ryan Walker:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
{2}
K262021 - Ryan Walker
Page 2
When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
{3}
K262021 - Ryan Walker
Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
NAIRA MURADYAN -S
Naira Muradyan, PhD
Assistant Director
DHT5A: Division of Neurosurgical,
Neurointerventional, and
Neurodiagnostic Devices
OHT5: Office of Neurological and
Physical Medicine Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{4}
# Indications for Use
| Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | | K262021 | ? |
| --- | --- | --- | --- |
| Please provide the device trade name(s). | | | ? |
| Toro 71 Aspiration Catheter; Toro Aspiration Tubing | | | |
| Please provide your Indications for Use below. | | | ? |
| The Toro Aspiration Catheter, with the Toro Aspiration Tubing and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy or who fail thrombolytic drug therapy are candidates for treatment. The Toro Aspiration Tubing is intended to connect the Toro Aspiration Catheter to the canister of a compatible aspiration pump and to allow the user to control the fluid flow. | | | |
| Please select the types of uses (select one or both, as applicable). | | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? |
| Please select the age group(s) for which the device(s) is to be used. | | ☐ Neonates/Newborns (Birth to < 29 days old) ☐ Infants (29 days old to < 2 years old) ☐ Children (2 years old to < 12 years old) ☐ Adolescents (12 years old to < 22 years old) ☑ Adults (22 years old and greater) | ? |
{5}
toro
neurovascular
K262021
## 510(k) Summary
| Date Prepared: | October 20, 2026 |
| --- | --- |
| Device Classification Name: | Catheter, Thrombus Retriever |
| Device Name: | Toro 71 Aspiration Catheter; Toro Aspiration Tubing |
| Applicant: | Toro Neurovascular, Inc. 470 Wald Irvine, CA 92618 |
| Applicant Contact: | Ryan Walker Chief Operating Officer 657-229-1108 |
| Regulation Number: | 21 CFR 870.1250 |
| Classification Product Code: | NRY |
| Regulation Medical Specialty: | Cardiovascular |
| 510(k) Review Panel: | Neurology |
| Predicate Device: | ZOOM (71, 55, 45, 35) Reperfusion Catheters; ZOOM Aspiration Tubing (K202182) |
### Device Description:
The Toro 71 Aspiration Catheter is a variable stiffness, single lumen catheter designed to remove thrombus from the tortuous neurovasculature using aspiration. The catheter shaft design includes stainless steel and nitinol wires and polymers of varying durometers. The catheter incorporates an internal lubricious liner to facilitate its advancement over a steerable guidewire or microcatheter. To reduce friction during manipulation, a hydrophilic coating is applied to the distal exterior section of the catheter shaft. A single radiopaque tip marker provides visualization under fluoroscopy. The proximal end of the catheter includes a hub with Luer lock. The catheter is supplied sterile, for single use only.
The Toro Aspiration Tubing is comprised of a flexible braided tube which is bonded to a standard Luer fitting that connects to the Toro Aspiration Catheter and a slip fit connector that connects to the canister on the aspiration pump. A flow control switch provides users with the ability to apply vacuum to the Toro Aspiration Catheter. The Toro Aspiration Tubing is made of common medical grade polymers, is provided sterile, and is intended for single use only.
### Indications for Use:
The Toro Aspiration Catheter, with the Toro Aspiration Tubing and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy or who fail thrombolytic drug therapy are candidates for treatment.
The Toro Aspiration Tubing is intended to connect the Toro Aspiration Catheter to the canister of a compatible aspiration pump and to allow the user to control the fluid flow.
Page 1 of 9
{6}
toro
neurovascular
K262021
Comparison with the Predicate Device:
| Table 1: Toro 71 Aspiration Catheter | | |
| --- | --- | --- |
| Device Attribute | ZOOM (71, 55, 45, 35) Reperfusion Catheters (K202182) | Toro 71 Aspiration Catheter (K262021) |
| Indications for Use Statement | The ZOOM Reperfusion Catheters, with the ZOOM Aspiration Tubing and ZOOM Aspiration Pump (or equivalent vacuum pump), are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment. | The Toro Aspiration Catheter, with the Toro Aspiration Tubing and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy or who fail thrombolytic drug therapy are candidates for treatment. |
| Classification Product Code | NRY | Same as K202182 |
| Regulation Number | 21 CFR 870.1250 | Same as K202182 |
| Regulation Medical Specialty | Cardiovascular | Same as K202182 |
| Review Panel | Neurology | Same as K202182 |
| Design Feature(s) | | |
| Tip | Beveled Distal Edge, Soft, Flexible, Atraumatic | Straight Distal Edge, Soft, Flexible, Atraumatic |
| Proximal Inner Diameter | 0.071" (Zoom 71) | Same as K202182 |
| Proximal Outer Diameter | 0.083" (Zoom 71) | Same as K202182 |
| Distal Inner Diameter | 0.071" (Zoom 71) | Same as K202182 |
| Distal Outer Diameter | 0.083" (Zoom 71) | Same as K202182 |
| Effective Length | 137 cm (Zoom 71) | 118 cm 132 cm 137 cm |
| Materials | | |
| Distal Catheter Shaft | Reinforced with metals and polymers | Same as K202182 |
| Proximal Catheter Shaft | Reinforced with metals and polymers | Same as K202182 |
| Coating | Hydrophilic coating | Same as K202182 |
Page 2 of 9
{7}
toro
neurovascular
K262021
| Table 1: Toro 71 Aspiration Catheter | | |
| --- | --- | --- |
| Device Attribute | ZOOM (71, 55, 45, 35) Reperfusion Catheters (K202182) | Toro 71 Aspiration Catheter (K262021) |
| Materials | Commonly used medical grade plastics and metals with hydrophilic coating | Same as K202182 |
| Packaging | | |
| Accessories | Rotating Hemostasis Valve (RHV) | Rotating Hemostasis Valve Split Introducer Sheath Shaping Mandrel |
| Configuration | The catheter is placed in a protective polyethylene tube, mounted with accessory RHV onto a polyethylene packaging card, placed into a pouch, sealed and labeled. The sealed pouch and IFU are placed in a labeled shelf carton box. | The catheter is placed in a protective polyethylene tube, mounted with accessory RHV, split introducer sheath, and shaping mandrel onto a high-density polyethylene backer card, placed into a pouch, sealed, and labeled. The sealed pouch and Instructions for Use are placed inside a labeled shelf carton. |
| Shelf Life | | |
| Shelf Life | 36 Months | 12 Months |
| Sterility | | |
| Sterilization Method | Ethylene Oxide | Same as K202182 |
| Sterility Assurance Level (SAL) | \( 10^{-6} \) | Same as K202182 |
| Compatibility | | |
| Aspiration Source | ZOOM Aspiration Pump (or equivalent vacuum pump) | Commercially Available Aspiration Pump. High-flow / high-vacuum medical suction pump that provides constant vacuum during use (vacuum pressures between -20 inHg and -29.9 inHg) and is capable of delivering a free air flow rate up to 0.8 SCFM (23 L/min). |
Page 3 of 9
{8}
toro
neurovascular
K262021
Table 2: Toro Aspiration Tubing
| Device Attribute | ZOOM Aspiration Tubing (K202182) | Toro Aspiration Tubing (K262021) |
| --- | --- | --- |
| Indications for Use | The ZOOM Aspiration Tubing is intended to connect the ZOOM Reperfusion Catheter to the ZOOM Canister of the ZOOM Aspiration Pump and to allow the user to control the fluid flow. | The Toro Aspiration Tubing is intended to connect the Toro Aspiration Catheter to the canister of a compatible aspiration pump and to allow the user to control the fluid flow. |
| Condition Supplied | Sterile and Single Use | Same as K202182 |
| Sterilization Method | Ethylene Oxide | Same as K202182 |
| Sterility Assurance Level (SAL) | 10^{-6} | Same as K202182 |
| Tubing ID | 0.110" | Same as K202182 |
| Tubing Length | 104" | 110" |
| Flow Control Mechanism | Flow Control Clamp | Flow Control Switch |
Page 4 of 9
{9}
[Non-Text]
toro
neurovascular
K262021
### Biocompatibility – Toro 71 Aspiration Catheter:
The Toro 71 Aspiration Catheter is categorized as an external communicating device, which contacts circulating blood for a limited duration ( \( \leq \) 24 hours). The risk management process determined that the biocompatibility testing conducted on the Toro 88 Superbore Catheter (K252297) adequately assessed the biocompatibility profile of the subject device for the endpoints recommended by the FDA biocompatibility guidance, “Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”.
Packaging – Toro 71 Aspiration Catheter:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Visual Inspection | The Toro 71 Aspiration Catheter was evaluated per ASTM F1886/F1886M-16. | Pass |
| Seal Width | The Toro 71 Aspiration Catheter was evaluated by measuring pouch seals to verify sufficient seal width to ensure sterility after distribution. | Pass |
| Bubble Leak | The Toro 71 Aspiration Catheter was evaluated per ASTM F2096-11 (2019). | Pass |
| Seal Strength | The Toro 71 Aspiration Catheter was evaluated per ASTM F88/F88M-23. | Pass |
Sterilization – Toro 71 Aspiration Catheter:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Ethylene Oxide Residual | The Toro 71 Aspiration Catheter was evaluated per ISO 10993-7:2008/Amd 1:2019. | Pass |
| Ethylene Chlorohydrin Residual | The Toro 71 Aspiration Catheter was evaluated per ISO 10993-7:2008/Amd 1:2019. | Pass |
| Bacterial Endotoxin Testing | The Toro 71 Aspiration Catheter was evaluated per AAMI/ANSI ST72:2019 and USP-<85>. | Pass |
Performance Data – Bench – Toro 71 Aspiration Catheter:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Design Verification | | |
| Dimensional Verification | The Toro 71 Aspiration Catheter was evaluated to ensure the dimensional specifications were met for inner diameter, outer diameter, coating length, and working length. | Pass |
| Visual Inspection | The Toro 71 Aspiration Catheter was evaluated to ensure the device met the surface requirements per ISO 10555-1:2023, §4.7. | Pass |
| Simulated Use | The Toro 71 Aspiration Catheter was evaluated to verify the performance of the device as it relates to device preparation, maneuverability, durability, compatibility, clot removal, resistance to lumen collapse under aspiration, burst pressure, and torque strength. | Pass |
Page 5 of 9
{10}
toro
neurovascular
K262021
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Tensile Strength | The Toro 71 Aspiration Catheter was tested in accordance with ISO 10555-1:2023, Annex B to ensure the device has sufficient strength to withstand tensile forces throughout a procedure. | Pass |
| Coating Lubricity | The Toro 71 Aspiration Catheter was evaluated to ensure the frictional forces are comparable to or less than the predicate device. | Pass |
| Particulate Evaluation | The Toro 71 Aspiration Catheter was evaluated to ensure the particulate count and size distribution (≥10μm, ≥25μm, and ≥50μm) are comparable to or less than the predicate device. | Pass |
| Coating Length | The Toro 71 Aspiration Catheter was evaluated to ensure the dimensional specification was met for coating length. | Pass |
| Coating Integrity | The Toro 71 Aspiration Catheter was evaluated post-simulated use to ensure the coating was free of defects that contribute to unacceptable particulate generation. | Pass |
| Kink Resistance | The Toro 71 Aspiration Catheter was evaluated to ensure the catheter shaft does not kink when navigating anatomically relevant bends with varying radii. | Pass |
| Liquid Leakage – Positive Pressure | The Toro 71 Aspiration Catheter was evaluated to ensure the device remains leak free when tested in accordance with ISO 10555-1:2023, Annex C. | Pass |
| Flowrate – Positive Pressure | The Toro 71 Aspiration Catheter was evaluated to ensure the flowrate (positive pressure) of the device was comparable to the predicate device when tested in accordance with ISO 10555-1:2023, Annex E. | Pass |
| Flowrate – Vacuum Pressure | The Toro 71 Aspiration Catheter was evaluated to ensure the flowrate (negative pressure) of the device was comparable to the predicate device. | Pass |
| Distal Tip Stiffness | The Toro 71 Aspiration Catheter was evaluated to ensure the distal tip stiffness of the device was comparable to or lower than the predicate device. | Pass |
| Radiopacity | The Toro 71 Aspiration Catheter was evaluated to ensure the marker band is radiopaque. | Pass |
Page 6 of 9
{11}
toro
neurovascular
K262021
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Small-Bore Connectors | The Toro 71 Aspiration Catheter was evaluated to ensure the dimensional and performance requirements were met per ISO 80369-7:2021 and ISO 80369-20:2024. | Pass |
| Compatibility | The Toro 71 Aspiration Catheter was evaluated to ensure it is compatible with syringes and contrast media. | Pass |
| Air Leakage | The Toro 71 Aspiration Catheter was evaluated to ensure the device remains leak free when tested in accordance with ISO 10555-1:2023, Annex D. | Pass |
| Static Burst Pressure | The Toro 71 Aspiration Catheter was tested in accordance with ISO 10555-1:2023, Annex F to ensure the device does not burst under pressure that could be seen when performing contrast injections. | Pass |
| Torque Strength | The Toro 71 Aspiration Catheter was evaluated to ensure the torque strength of the device was comparable to commercially available devices. | Pass |
| **Design Validation and Usability Engineering** | | |
| Design Validation | The Toro 71 Aspiration Catheter was evaluated to validate the performance of the device, including its packaging and labeling, with intended clinical users. | Pass |
| Usability Engineering | The Toro 71 Aspiration Catheter was evaluated for usability per IEC 62366-1:2015/Amd 1:2020. | Pass |
Biocompatibility – Toro Aspiration Tubing:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| L929 MEM Elution Test – ISO | The Toro Aspiration Tubing was evaluated per ISO 10993-5:2009. | Pass |
| Kligman Maximization Test – ISO | The Toro Aspiration Tubing was evaluated per ISO 10993-10:2021. | Pass |
| Intracutaneous Injection Test – ISO | The Toro Aspiration Tubing was evaluated per ISO 10993-10:2021. | Pass |
Packaging – Toro Aspiration Tubing:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Visual Inspection | The Toro Aspiration Tubing was evaluated per internal requirements. | Pass |
| Bubble Emission | The Toro Aspiration Tubing was evaluated per ASTM F2096-11 (2019). | Pass |
| Dye Penetration | The Toro Aspiration Tubing was evaluated per ASTM F1929-23 and ASTM F3039-15. | Pass |
Page 7 of 9
{12}
[Non-Text]
toro
neurovascular
K262021
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Burst | The Toro Aspiration Tubing was evaluated per ASTM F1140-13. | Pass |
Sterilization – Toro Aspiration Tubing:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Ethylene Oxide Residual | The Toro Aspiration Tubing was evaluated per ISO 10993-7:2008/Amd 1:2019. | Pass |
| Ethylene Chlorohydrin Residual | The Toro Aspiration Tubing was evaluated per ISO 10993-7:2008/Amd 1:2019. | Pass |
| Bacterial Endotoxin Testing | The Toro Aspiration Tubing was evaluated per AAMI/ANSI ST72:2019 and USP-<85>. | Pass |
Performance Data – Bench – Toro Aspiration Tubing:
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Design Verification | | |
| Dimensional Verification | The Toro Aspiration Tubing was evaluated to ensure the dimensional specifications were met for the inner diameter and total length. | Pass |
| Vacuum Force | The Toro Aspiration Tubing with the Toro 71 Aspiration Catheter was evaluated to ensure the vacuum force of the device was comparable to the predicate device. | Pass |
| Lumen Integrity (Resistance to Collapse) | The Toro Aspiration Tubing was evaluated to verify the lumen integrity (resistance to collapse) under maximum vacuum conditions. | Pass |
| Flow Control Functionality | The Toro Aspiration Tubing was evaluated to verify the flow control functionality under maximum vacuum conditions. | Pass |
| Freedom from Leakage | The Toro Aspiration Tubing was evaluated to ensure the vacuum pressure delivered was consistent with the pump. | Pass |
| Tensile Strength | The Toro Aspiration Tubing was evaluated to ensure the tensile strength of the device was comparable to or greater than commercially available devices. | Pass |
| Aspiration Flowrate | The Toro Aspiration Tubing was evaluated with the Toro 71 Aspiration Catheter and compatible aspiration pump to ensure the aspiration flowrate of the device was comparable to or greater than commercially available devices. | Pass |
| Compatibility | The Toro Aspiration Tubing was evaluated to ensure it was compatible with vacuum pumps and the Toro 71 Aspiration Catheter. | Pass |
Page 8 of 9
{13}
toro
neurovascular
K262021
| Test | Test Method Summary | Result |
| --- | --- | --- |
| Design Validation and Usability Engineering | | |
| Design Validation | The Toro Aspiration Tubing was evaluated to validate the performance of the device, including its packaging and labeling, with intended clinical users. | Pass |
| Usability Engineering | The Toro Aspiration Tubing was evaluated for usability per IEC 62366-1:2015/Amd 1:2020. | Pass |
The shelf-life of 12-months for the Toro 71 Aspiration Catheter and the Toro Aspiration Tubing was supported by bench tests and packaging integrity tests of the devices following accelerated aging to the labeled shelf-life.
#### Performance Data – Animal:
A Good Laboratory Practices (GLP) animal study was conducted to evaluate the safety, performance, and usability of the Toro 71 Aspiration Catheter and Toro Aspiration Tubing in comparison to a comparable marketed aspiration catheter and aspiration tubing in a porcine model. Six (6) animals were evaluated at 2- to 3-day and 30- to 32-day timepoints through thrombectomy treatments/retrieval of firm or soft clots and by performing a simulated aspiration (aspiration with no exogenous clot at the treatment site) with the catheter wedged in the vessel. Device usability, angiographic safety evaluations, gross necropsy, and comprehensive histopathological examination were performed. All animals remained clinically healthy throughout the duration of the in-life period with no significant health concerns or other complications related to the test articles. Clinical pathology results were similarly unremarkable, with no trending or attribution of abnormalities to the test articles. The gross and histological data were highly similar between the test and control article groups. Overall, the success criteria for the Toro 71 Aspiration Catheter and Toro Aspiration Tubing were met.
#### Performance Data – Clinical:
A determination of substantial equivalence is based upon successful completion of bench performance testing and animal testing.
#### Conclusion:
The Toro 71 Aspiration Catheter and Toro Aspiration Tubing are substantially equivalent to the ZOOM (71, 55, 45, 35) Reperfusion Catheters and ZOOM Aspiration Tubing (K202182) based on the same intended use and similar technological characteristics. The differences do not raise new or different questions of safety and effectiveness. The successful completion of non-clinical testing supports that the device meets the design specifications and performs as intended.
Page 9 of 9
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Guidance alerts
New and changed FDA guidance documents, emailed as a daily digest.
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the ? button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only Software as a Medical Device, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (Software as a Medical Device), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.